Nicole C. Van Der Merwe

Stellenbosch, WC, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

First functional evidence that a rare germline TP53β variant drives senescence-associated immune suppression and impairs apoptosis and cell migration in breast cancer patients.

First functional evidence that a rare germline TP53β variant drives senescence-associated immune suppression and impairs apoptosis and cell migration in breast cancer patients.

Journal: Translational oncology

Published: July 23, 2025

Incorporating familial risk, lifestyle factors, and pharmacogenomic insights into personalized noncommunicable disease (NCD) reports for healthcare funder beneficiaries participating in the Open Genome Project.

Incorporating familial risk, lifestyle factors, and pharmacogenomic insights into personalized noncommunicable disease (NCD) reports for healthcare funder beneficiaries participating in the Open Genome Project.

Journal: Annals of human genetics

Published: May 07, 2024

Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings.

Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings.

Journal: Frontiers in genetics

Published: January 28, 2022

A South African Indian population group dataset for breast cancer and BRCA1/2 variants.

A South African Indian population group dataset for breast cancer and BRCA1/2 variants.

Journal: Data in brief

Published: December 20, 2021

Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study.

Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study.

Journal: Frontiers in oncology

Published: October 20, 2020

Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.

Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter.

Journal: Wellcome open research

Published: August 06, 2020

Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.

Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.

Journal: Frontiers in genetics

Published: September 10, 2019

Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.

Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.

Journal: International journal of molecular sciences

Published: January 02, 2017

Genomic medicine and risk prediction across the disease spectrum.

Genomic medicine and risk prediction across the disease spectrum.

Journal: Critical reviews in clinical laboratory sciences

Published: January 20, 2015

Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application.

Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application.

Journal: Metabolic brain disease

Published: October 15, 2013

Two double heterozygotes in a South African Afrikaner family: implications for BRCA1 and BRCA2 predictive testing.

Two double heterozygotes in a South African Afrikaner family: implications for BRCA1 and BRCA2 predictive testing.

Journal: Clinical genetics

Published: April 11, 2012

CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application.

CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application.

Journal: Metabolic brain disease

Published: January 04, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026